AAAS: Remdesivir and interferon fall flat in WHO’s megastudy of COVID-19 treatments

“In a U.S. trial with more than 1000 COVID-19 patients published last week, those who received remdesivir had a shorter recovery time than patients in the control group, but there was no significant difference in mortality.” Remdesivir and interferon fall flat in WHO’s megastudy of COVID-19 treatments: Science Magazine AAAS   Patients get tested for …

AAAS: Remdesivir and interferon fall flat in WHO’s megastudy of COVID-19 treatments Read More »